← Eichor
Study identifier: NCT07576582 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Peloid Therapy in Temporomandibular Joint Dysfunction

Condition: Temporomandibular Disorders (TMDs) · Pain · Otalgia  ·  Sponsor: Uşak University

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

This prospective, single-group clinical study will evaluate whether local peloid therapy improves pain and jaw function in adults with temporomandibular joint dysfunction. Participants will receive peloid therapy applied to the temporomandibular joint region and masticatory muscles for 20 minutes per session, 5 days per week, for 2 weeks. Pain and functional outcomes will be measured at baseline and at the end of treatment using validated clinical scales, including the Jaw Functional Limitation Scale-8, visual analog scale pain scores, Fonseca index, maximum mouth opening, and secondary otalgia assessment.

This description comes directly from the study's public registry record.

Talk to the study team

Faruk Kadri Bakkal, MD, Asistant Professor  ·  +90 276 224 00 00  ·  fkbakkal@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Uşak University Faculty of MedicineUşak, Merkez, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07576582